Replies to post #192420 on Biotech Values

[DewDiligence]

SYK acquires IVTY for $7.40/sh in cash—a 29% premium to yesterday’s close—but a 38% discount to IVTY’s 2015 IPO price (#msg-114547833).

https://globenewswire.com/news-release/2018/09/11/1569100/0/en/Invuity-Announces-Definitive-Agreement-to-Be-Acquired-by-Stryker-Corporation-for-7-40-Per-Share-in-Cash.html

The nominal deal value is $190M.

This is SYK’s second buyout of a public company in the past two weeks (#msg-143281972).